Medicina intensiva · 2026
Management of severe infections by multi-resistant Gram-negative bacteria in critically ill patients.
СтатьяОбзорНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Garnacho-Montero José, Adriaensens-Pérez María, Aldabó-Pallás Teresa, Anaya-Carrión Noelia, Andaluz-Ojeda David, Cantón-Bulnes Luisa, De Pascale Gennaro, Fernández-Delgado Esperanza, Povoa Pedro, Ramírez-Gallemore Paula, Rodríguez-Oviedo Alejandro, Soriano Cruz
Аннотация
Infections caused by multi-resistant Gram-negative bacilli (MDR-GNB) are currently one of the main public health problems worldwide. Various mechanisms such as altered permeability, efflux pumps, or the appearance of inactivating enzymes (β-lactamases or carbapenemases, among others) cause these bacteria to develop resistance to many of the traditional therapeutic options. Since 2015, new broad-spectrum antibiotics have been incorporated, transforming the treatment of infections caused by MDR-GNB. This article, with an eminently practical focus, aims to review and update the diagnosis and treatment of infections caused by MDR-GNB in critically ill patients, attempting to position the use of new antibiotics both in targeted and empirical, without forgetting the crucial role of infection control in combating this health threat.